Identification of glyoxalase 1 polymorphisms associated with enzyme activity

Gene

Volumn 515, Issue 1, 2013, Pages 140-143

  Peculis, Raitis ^a   Konrade, Ilze ^b,d   Skapare, Elina ^c,d   Fridmanis, Davids ^a   Nikitina Zake, Liene ^a   Lejnieks, Aivars ^b,d   Pirags, Valdis ^e,f   Dambrova, Maija ^c,d   Klovins, Janis ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^c LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^d RIGA STRADINS UNIVERSITY   (Latvia)

^e UNIVERSITY OF LATVIA   (Latvia)

^f PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Diabetes; Glyoxalase 1; SNP

Indexed keywords

GLYOXALASE; GLYOXALASE 1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; FEMALE; GENOTYPE; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84872276698     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.11.009     Document Type: Article

References (23)

1. Barua M., Jenkins E.C., Chen W., Kuizon S., Pullarkat R.K., Junaid M.A. Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity-implications for autism. Autism Res. 2011, 4:262-270.
2. Berner A.K., et al. Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia 2012, 55:845-854.
3. Bierhaus A., et al. Methylglyoxal modification of Na(v)1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat. Med. 2012, 18:926-933.
4. Brest P., et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat. Genet. 2011, 43:242-245.
5. Distler M.G., et al. Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal. J. Clin. Invest. 2012, 122:2306-2315.
6. Donner J., et al. An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders. Biol. Psychiatry 2008, 64:672-680.
7. Engelen L., et al. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. J. Hypertens. 2009, 27:1399-1403.
8. Hovatta I., et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005, 438:662-666.
9. Ignatovica V., et al. Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population. Mol. Biol. Rep. 2012, 39:1917-1925.
10. Jack M.M., Ryals J.M., Wright D.E. Protection from diabetes-induced peripheral sensory neuropathy - a role for elevated glyoxalase I?. Exp. Neurol. 2012, 234:62-69.
11. Junaid M.A., Kowal D., Barua M., Pullarkat P.S., Sklower Brooks S., Pullarkat R.K. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am. J. Med. Genet. A 2004, 131:11-17.
12. Kompf J., Bissbort S., Ritter H. Red cell glyoxalase i (E.C.: 4.4.1.5): formal genetics and linkage relations. Humangenetik 1975, 28:249-251.
13. Morcos M., et al. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 2008, 7:260-269.
14. Purcell S., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
15. Rehnstrom K., Ylisaukko-Oja T., Vanhala R., von Wendt L., Peltonen L., Hovatta I. No association between common variants in glyoxalase 1 and autism spectrum disorders. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2008, 147B:124-127.
16. Saxena R., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
17. Skapare, E., Konrade, I., Liepinsh, E., Strele, I., Makrecka, M., Bierhaus, A., Lejnieks, A., Pirags, V., Dambrova, M., in press. Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients, Journal of Diabetes and Its Complications.
18. Skapare E., et al. Flow cytometric analysis of glyoxalase-1 expression in human leukocytes. Cell Biochem. Funct. 2011, 29:171-174.
19. Thornalley P.J. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem. J. 1990, 269:1-11.
20. Thornalley P.J. Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 2003, 31:1343-1348.
21. Thornalley P.J., Rabbani N. Glyoxalase in tumourigenesis and multidrug resistance. Semin. Cell Dev. Biol. 2011, 22:318-325.
22. Wautier J.L., Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ. Res. 2004, 95:233-238.
23. Wu J.C., Li X.H., Peng Y.D., Wang J.B., Tang J.F., Wang Y.F. Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. J. Endocrinol. Invest. 2011, 34:343-348.